3-(4-mexiletino)-1-propanesulfonic acid

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 3-(4-mexiletino)-1-propanesulfonic acid
• 英文别名: 3-[1-(2,6-Dimethylphenoxy)propan-2-ylamino]propane-1-sulfonic acid
• 化学式: C₁₄H₂₃NO₄S
• 分子量: 301.407
• InChiKey: FDBYKKBZVBCBPU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.4
• 重原子数：
  20
• 可旋转键数：
  8
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  84
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  1,3-丙烷磺内酯 、 美西律 以 四氢呋喃 为溶剂， 反应 4.0h， 以56%的产率得到3-(4-mexiletino)-1-propanesulfonic acid
  参考文献：
  名称：

  [EN] METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES
  [FR] METHODES ET COMPOSITIONS POUR TRAITER LES MALADIES LIEES A L'AMYLOIDE

  摘要：

  公开号：

  WO2004113275A3

文献信息

• Methods and compositions for treating amyloid-related diseases
  申请人：Kong Xianqi

  公开号：US20070010573A1

  公开（公告）日：2007-01-11

  Methods, compounds, pharmaceutical compositions and kits are described for treating or preventing amyloid-related disease.

  描述了用于治疗或预防与淀粉样蛋白相关的疾病的方法、化合物、制药组合物和试剂盒。
• METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES
  申请人：Kong Xianqi

  公开号：US20100113591A1

  公开（公告）日：2010-05-06

  Methods, compounds, pharmaceutical compositions and kits are described for treating or preventing amyloid-related disease.

  本发明涉及用于治疗或预防淀粉样蛋白相关疾病的方法、化合物、制药组合物和试剂盒。
• METHOD FOR THE PREPARATION OF 1,3-PROPANE DISULFONIC ACID COMPOUNDS
  申请人：Kiacta Sàrl

  公开号：EP1646659B1

  公开（公告）日：2014-05-14
• PHARMACEUTICAL DRUG CANDIDATES AND METHODS FOR PREPARATION THEREOF
  申请人：Kong Xianqi

  公开号：US20080027097A1

  公开（公告）日：2008-01-31

  The present invention is directed to methods of preparation of sulfonate derivatized compounds, e.g., 3-amino-1-propanesulfonic acid and 1,3-propanedisulfonic acid disodium salt with increased purity, with reduced potential for toxic by-products, and that are pharmaceutically useful, e.g., for the treatment of amyloidosis.
• METHOD AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES
  申请人：Kong Xianqi

  公开号：US20120015911A1

  公开（公告）日：2012-01-19

  Methods, compounds, pharmaceutical compositions and kits are described for treating or preventing amyloid-related disease.